Also Try
Moderna (MRNA) stock sinks after new data shows the efficacy of its mRNA-based RSV vaccine fell sharply in the second year and was lower than that of rival vaccines marketed by GSK and Pfizer.
Zacks via Yahoo
1 day ago
Benzinga via Yahoo
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
Simply Wall St. via Yahoo
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
6 days ago
Why Is Moderna Stock Trading Lower On Wednesday?
2 days ago
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
3 days ago
Investing.com via Yahoo
Moderna shares decline, RSV vaccine efficacy lags behind competitors
Investing.com - Moderna Inc (NASDAQ:MRNA) experienced an 11% drop on Wednesday after the company disclosed that its respiratory syncytial virus (RSV) vaccine, mResvia, exhibited ...
View all
American biotechnology company
modernatx.com
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Wikipedia
Stock price: MRNA (NasdaqGS) $119.94 -1.24 (-1.02%)
Fri, Jun 28, 2024, 11:17AM EDT